Analyst consensus rating
Cerenome Analyst Rating: none
Direct answer
Cerenome's consensus rating is none.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $27.75.
Forecast evidence checked November 14, 2026.
Get free Cerenome email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.95
- Average price target
- $27.75
- High price target
- $43.00
- Low price target
- $12.00
- Low target gap
- +1,162.9%
- Target upside
- +2,820.4%
- High target gap
- +4,425.4%
- Target range width
- 3,262.5%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- November 14, 2026
- Valid through
- November 21, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Cerenome?
Cerenome has a verified none consensus. The same dataset has an average price target of $27.75.
How far are Cerenome's low and high targets from the recorded price?
The low target implies +1,162.9%, while the high target implies +4,425.4%.
How many analysts are included in Cerenome's consensus?
The verified consensus includes 4 analysts.
How is Cerenome's target upside or downside calculated?
The average target of $27.75 is divided by the recorded price of $0.95, then one is subtracted to produce +2,820.4%. This does not guarantee a future return.
When was Cerenome's analyst forecast verified?
The data was verified on 2026-11-14. The dataset is valid through 2026-11-21.